다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Petra Acquisition Inc (PAICW)
Petra Acquisition Inc (PAICW) 뉴스

PAICW

Petra Acquisition (PAICW)

Petra Acquisition Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PAICW

1

일자	시간	출처	헤드라인	심볼	기업
2021/12/22	23:00	GlobeNewswire Inc.	Petra Acquisition, Inc. Announces Share Redemption Backstop and Forward Purchase Agreements in Connection with Revelation Biosciences, Inc. Business Combination	NASDAQ:PAICW	Petra Acquisition Inc
2021/12/17	06:15	GlobeNewswire Inc.	Petra Acquisition, Inc. Announces Special Meeting of Stockholders to Approve Business Combination with Revelation Biosciences, Inc.	NASDAQ:PAICW	Petra Acquisition Inc
2021/12/07	06:01	GlobeNewswire Inc.	Revelation Biosciences Inc. Appoints Joseph A. Bellanti, M.D. to Scientific Advisory Board	NASDAQ:PAICW	Petra Acquisition Inc
2021/12/02	06:01	GlobeNewswire Inc.	Revelation Biosciences Inc. Announces Initiation of a Phase 2b Study to Assess Efficacy of Intranasal REVTx-99 for The Prevention of H3N2 Influenza	NASDAQ:PAICW	Petra Acquisition Inc
2021/11/29	23:00	GlobeNewswire Inc.	Revelation Biosciences Inc. Announces Creation and Appointments to Scientific Advisory Board	NASDAQ:PAICW	Petra Acquisition Inc
2021/11/15	23:00	GlobeNewswire Inc.	Revelation Biosciences Inc. Announces Initiation of a Phase 1b Clinical Study of REVTx-99 for the Experimental Treatment of Allergic Rhinitis and Chronic Nasal Congestion	NASDAQ:PAICW	Petra Acquisition Inc
2021/11/01	22:00	GlobeNewswire Inc.	Revelation Biosciences Inc. Engages Partnering Advisor, MedWorld Advisors, to Optimize Value of the Company’s Diagnostic Tool, REVID™	NASDAQ:PAICW	Petra Acquisition Inc
2021/10/26	05:01	GlobeNewswire Inc.	Revelation Biosciences Inc. Engages Destum Partners Inc. to Identify Strategic Partners for REVTx-99 (Ex-US) and REVTx-200 (Worldwide)	NASDAQ:PAICW	Petra Acquisition Inc
2021/10/04	22:00	GlobeNewswire Inc.	Revelation Biosciences Inc. Receives Approval to Begin a Phase 1b Clinical Study of REVTx-99 as an Experimental Treatment for Allergic Rhinitis and Chronic Nasal Congestion	NASDAQ:PAICW	Petra Acquisition Inc
2021/09/28	22:00	GlobeNewswire Inc.	Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of REVTx 99, an Experimental Prophylactic Treatment for the Prevention of Respiratory Viral Infections	NASDAQ:PAICW	Petra Acquisition Inc
2021/08/30	19:00	Business Wire	Revelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded Through a Merger with Petra Acquisition, Inc.	NASDAQ:PAICW	Petra Acquisition Inc

검색 관련기사 보기:NASDAQ:PAICW

1

Financial Select Sector

Health Care Select Sector

American Express

Deutsche Telekom (QX)

US Dollar vs Sterling

JP Morgan Chase

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관